Dr. Salvador Borrós Gómez
Tractivus project pretends to evolve to a start up company able to become a solution provider to the society and the medical community reducing the interventions associated to stents implantation, increasing the health quality of the patients and reduce the costs associated to stent interventions. At this point, Tractivus technology can be implemented with different agreements with Public Health Systems, Hospitals and Private Insurance Companies causing a costs reduction around 10 times due to reduction of side effects and microbial contamination.
At this point, LLAVOR, supported from Agaur, will allow the development of the proof of concept, in a compassionate approach, to demonstrate the validity of the technology. This achievement will lead to the creation of Tractivus, the start up, to bring the technology to the market.